🇺🇸 FDA

Intelligence Platform

Patents

Browse 41 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11690839

Treatment of idiopathic pulmonary fibrosis

TAKEDA GMBH · Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11179384

Treatment of nonalcoholic fatty liver disease

TAKEDA GMBH · Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11173208

Liquid formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10758621

Liquid formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10745475

Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as anal

TAKEDA GMBH · Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9962377

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

TAKEDA GMBH · Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9919051

Liquid formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833410

Lyophilized formulation comprising GM-CSF neutralizing compound

TAKEDA GMBH · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422327

Process for preparing crystalline ciclesonide with defined particle size

TAKEDA GMBH · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9387205

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9376442

Methylpyrrolopyrimidinecarboxamides

TAKEDA GMBH · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9340522

Pyrazolone-derivatives and their use as PDE-4 inhibitors

TAKEDA GMBH · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9309187

EP2 receptor agonists

TAKEDA GMBH · Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9205044

Aqueous pharmaceutical preparation comprising roflumilast

TAKEDA GMBH · Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9149479

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9090597

Pyrazolone derivatives as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9018175

3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives

TAKEDA GMBH · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8927557

Methylpyrrolopyrimidinecarboxamides

TAKEDA GMBH · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883818

Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865745

Pyrazolone derivatives as PDE4 inhibitors

TAKEDA GMBH · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8829189

Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

TAKEDA GMBH · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8816085

Methylpyrrolopyridinecarboxamides

TAKEDA GMBH · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8758817

Dosage form containing (S)-pantoprazole as active ingredient

TAKEDA GMBH · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8754218

Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

TAKEDA GMBH · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted